Thomas J. Layden

Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy

Avidan U. Neumann, Nancy P. Lam, Harel Dahari et al. · Science · 1998 · 2.1K citations

Modelling how ribavirin improves interferon response rates in hepatitis C virus infection

Narendra M. Dixit, Jennifer E. Layden‐Almer, Thomas J. Layden et al. · Nature · 2004 · 369 citations

Viral Persistence, Hepatology, Viral Hepatitis +8

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life

Jérémie Guedj, Harel Dahari, Libin Rong et al. · Proceedings of the National Academy of Sciences · 2013 · 335 citations · Full text

Shorter Estimate, Viral Persistence, Hepatitis C +14

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

Natalie Lam, Avidan U. Neumann, David R. Gretch et al. · Hepatology · 1997 · 329 citations · Full text

A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C†

Hongjin Huang, Mitchell L. Shiffman, Scott L. Friedman et al. · Hepatology · 2007 · 298 citations · Full text